» Authors » M E Kruijshaar

M E Kruijshaar

Explore the profile of M E Kruijshaar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 373
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Ploeg A, Kruijshaar M, Toscano A, Laforet P, Angelini C, Lachmann R, et al.
Eur J Neurol . 2017 May; 24(6):768-e31. PMID: 28477382
Background And Purpose: Pompe disease is a rare inheritable muscle disorder for which enzyme replacement therapy (ERT) has been available since 2006. Uniform criteria for starting and stopping ERT in...
2.
Karabul N, Kruijshaar M, Schober A, Gungor D, Hanisch F
Mol Genet Metab Rep . 2016 Nov; 1:139-140. PMID: 27896083
No abstract available.
3.
Gungor D, Kruijshaar M, Plug I, Rizopoulos D, Kanters T, Wens S, et al.
J Neuromuscul Dis . 2016 Nov; 2(s1):S63. PMID: 27858652
No abstract available.
4.
van der Meijden J, Gungor D, Kruijshaar M, Muir A, Broekgaarden H, van der Ploeg A
J Neuromuscul Dis . 2016 Nov; 2(s1):S35. PMID: 27858630
No abstract available.
5.
Kanters T, Redekop W, Kruijshaar M, van der Ploeg A, Rutten-van Molken M, Hakkaart L
Qual Life Res . 2014 Oct; 24(4):837-44. PMID: 25342117
Purpose: Comparative studies between Euroqol-5D (EQ-5D) and ShortForm 6D (SF-6D) utilities have been performed for a number of diseases, but not yet for orphan diseases. Pompe disease is an orphan...
6.
van der Meijden J, Gungor D, Kruijshaar M, Muir A, Broekgaarden H, van der Ploeg A
J Inherit Metab Dis . 2014 Aug; 38(3):495-503. PMID: 25112389
Pompe disease is a rare, progressive lysosomal storage disorder for which enzyme therapy (ERT) became available in 2006. Four years earlier, the IPA/Erasmus MC survey, an international longitudinal prospective survey,...
7.
Gungor D, Schober A, Kruijshaar M, Plug I, Karabul N, Deschauer M, et al.
Mol Genet Metab . 2013 Jul; 109(4):371-6. PMID: 23849261
Background: Pompe disease is a rare hereditary metabolic myopathy caused by a deficiency of acid-α-glucosidase. We investigated the presence and severity of pain and its interference with daily activities in...
8.
Millett E, Noel D, Mangtani P, Abubakar I, Kruijshaar M
Epidemiol Infect . 2012 Aug; 141(6):1223-31. PMID: 22846385
Completion of treatment is key to tuberculosis control. Using national surveillance data we assessed factors associated with tuberculosis patients being lost to follow-up before completing treatment ('lost'). Patients reported in...
9.
Crofts J, Kruijshaar M, Delpech V, Ncube F, Abubakar I
Epidemiol Infect . 2011 Nov; 140(10):1873-9. PMID: 22117103
This study used linked national tuberculosis (TB) and HIV surveillance data to investigate recent trends and factors associated with HIV co-infection (TB-HIV) in healthcare workers (HCWs) with TB in England...
10.
Pimpin L, Drumright L, Kruijshaar M, Abubakar I, Rice B, Delpech V, et al.
Eur Respir J . 2011 Jul; 38(6):1382-92. PMID: 21737549
In order to ensure the availability of resources for tuberculosis (TB) and HIV management and control, it is imperative that countries monitor and plan for co-infection in order to identify,...